|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/07/13 Morgan Stanley 10-Q 3/31/13 131:38M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 3.01M
2: EX-10.1 Material Contract HTML 99K
3: EX-10.2 Material Contract HTML 116K
4: EX-10.3 Material Contract HTML 124K
5: EX-10.4 Material Contract HTML 134K
6: EX-10.5 Material Contract HTML 131K
7: EX-10.6 Material Contract HTML 154K
8: EX-12 Statement re: Computation of Ratios HTML 80K
9: EX-15 Letter re: Unaudited Interim Financial Information HTML 48K
10: EX-31.1 Certification -- §302 - SOA'02 HTML 44K
11: EX-31.2 Certification -- §302 - SOA'02 HTML 44K
12: EX-32.1 Certification -- §906 - SOA'02 HTML 39K
13: EX-32.2 Certification -- §906 - SOA'02 HTML 39K
89: R1 Document and Entity Information HTML 66K
68: R2 Condensed Consolidated Statements of Financial HTML 208K
Condition
84: R3 Consolidated Statements of Financial Condition HTML 117K
(Parenthetical)
93: R4 Condensed Consolidated Statements of Income HTML 215K
119: R5 Condensed Consolidated Statements of Comprehensive HTML 104K
Income
71: R6 Condensed Consolidated Statements of Cash Flows HTML 200K
83: R7 Condensed Consolidated Statements of Changes in HTML 97K
Total Equity
62: R8 Introduction and Basis of Presentation HTML 71K
50: R9 Significant Accounting Policies HTML 53K
121: R10 Wealth Management Joint Venture HTML 49K
95: R11 Fair Value Disclosures HTML 1.10M
94: R12 Securities Available for Sale HTML 243K
101: R13 Collateralized Transactions HTML 105K
102: R14 Variable Interest Entities and Securitization HTML 306K
Activities
99: R15 Financing Receivables HTML 197K
103: R16 Goodwill and Net Intangible Assets HTML 84K
85: R17 Borrowings and Other Secured Financings HTML 65K
90: R18 Derivative Instruments and Hedging Activities HTML 409K
97: R19 Commitments, Guarantees and Contingencies HTML 176K
130: R20 Regulatory Requirements HTML 106K
112: R21 Redeemable Noncontrolling Interests and Total HTML 84K
Equity
77: R22 Earnings Per Common Share HTML 80K
96: R23 Interest Income and Interest Expense HTML 62K
80: R24 Employee Benefit Plans HTML 58K
40: R25 Income Taxes HTML 52K
113: R26 Segment and Geographic Information HTML 144K
126: R27 Equity Method Investments HTML 52K
56: R28 Discontinued Operations HTML 59K
55: R29 Subsequent Events HTML 46K
60: R30 Significant Accounting Policies (Policy) HTML 54K
61: R31 Fair Value Disclosures (Tables) HTML 1.02M
63: R32 Securities Available for Sale (Tables) HTML 237K
28: R33 Collateralized Transactions (Tables) HTML 94K
110: R34 Variable Interest Entities and Securitization HTML 266K
Activities (Tables)
75: R35 Financing Receivables (Tables) HTML 180K
78: R36 Goodwill and Net Intangible Assets (Tables) HTML 75K
45: R37 Borrowings and Other Secured Financings (Tables) HTML 58K
129: R38 Derivative Instruments and Hedging Activities HTML 368K
(Tables)
20: R39 Commitments, Guarantees and Contingencies (Tables) HTML 113K
65: R40 Regulatory Requirements (Tables) HTML 71K
117: R41 Redeemable Noncontrolling Interests and Total HTML 70K
Equity (Tables)
42: R42 Earnings Per Common Share (Tables) HTML 78K
54: R43 Interest Income and Interest Expense (Tables) HTML 61K
59: R44 Employee Benefit Plans (Tables) HTML 49K
69: R45 Segment and Geographic Information (Tables) HTML 141K
27: R46 Discontinued Operations (Tables) HTML 56K
49: R47 Introduction and Basis of Presentation (Details) HTML 40K
22: R48 Significant Accounting Policies (Details) HTML 43K
115: R49 Wealth Management Joint Venture (Details) HTML 60K
41: R50 Fair Value Disclosures (Narrative) (Details) HTML 48K
111: R51 Fair Value Disclosures (Assets and Liabilities HTML 335K
Measured at Fair Value on a Recurring Basis)
(Details)
46: R52 Fair Value Disclosures (Changes in Level 3 Assets HTML 279K
and Liabilities Measured at Fair Value on a
Recurring Basis) (Details)
66: R53 Fair Value Disclosures (Quantitative Information HTML 247K
about Recurring Level 3 Fair Value Measurements)
(Details)
21: R54 Fair Value Disclosures (Fair Value of Investments HTML 93K
that Calculate Net Asset Value) (Details)
24: R55 Fair Value Disclosures (Net Gains (Losses) Due to HTML 54K
Changes in Fair Value for Items Measured at Fair
Value Pursuant to the Fair Value Option Election)
(Details)
58: R56 Fair Value Disclosures (Short-term and Long-term HTML 45K
Borrowings) (Details)
32: R57 Fair Value Disclosures (Gains (Losses) Due to HTML 44K
Changes in Instrument Specific Credit Risk)
(Details)
122: R58 Fair Value Disclosures (Amount by Which HTML 54K
Contractual Principal Amount Exceeds Fair Value)
(Details)
73: R59 Fair Value Disclosures (Assets Measured at Fair HTML 118K
Value on a Nonrecurring Basis) (Details)
100: R60 Fair Value Disclosures (Financial Instruments Not HTML 140K
Carried at FV) (Details)
48: R61 Securities Available for Sale (Schedule of HTML 98K
Available for Sale Securities) (Details)
51: R62 Securities Available for Sale (Schedule of HTML 91K
Available for Sale Securities in an Unrealized
Loss Position) (Details)
108: R63 Securities Available for Sale (Schedule of HTML 128K
Amortized Cost and Fair Value of Available for
Sale Debt Securities by Contractual Date)
(Details)
104: R64 Securities Available for Sale (Schedule of HTML 49K
Proceeds of Sale of Securities Available for Sale)
(Details)
76: R65 Collateralized Transactions (Narrative) (Details) HTML 48K
106: R66 Collateralized Transactions (Balance Sheet HTML 97K
Offsetting) (Details)
47: R67 Collateralized Transactions (Financial Instruments HTML 43K
Owned That Have Been Loaned Or Pledged To
Counterparties) (Details)
81: R68 Collateralized Transactions (Cash And Securities HTML 48K
Deposited With Clearing Organizations Or
Segregated Under Federal And Other Regulations Or
Requirements) (Details)
125: R69 Variable Interest Entities and Securitization HTML 59K
Activities (Narrative) (Details)
23: R70 Variable Interest Entities and Securitization HTML 48K
Activities (Consolidated VIEs) (Details)
39: R71 Variable Interest Entities and Securitization HTML 122K
Activities (Non-Consolidated VIEs) (Details)
67: R72 Variable Interest Entities and Securitization HTML 76K
Activities (Information Regarding SPEs) (Details)
30: R73 Variable Interest Entities and Securitization HTML 64K
Activities (Fair Value of Assets and Liabilities)
(Details)
128: R74 Variable Interest Entities and Securitization HTML 45K
Activities (Transfers of Assets Treated as Secured
Financings) (Details)
43: R75 Variable Interest Entities and Securitization HTML 59K
Activities (Mortgage Servicing Activities for
SPEs) (Details)
34: R76 Financing Receivables (Loans Held for Investment) HTML 66K
(Details)
38: R77 Financing Receivables (Loans and Lending-related HTML 142K
Commitments) (Details)
25: R78 Financing Receivables (Employee Loans) (Details) HTML 48K
29: R79 Goodwill and Net Intangible Assets (Changes in HTML 59K
Carrying Amount of Goodwill) (Details)
91: R80 Goodwill and Net Intangible Assets (Changes in HTML 67K
Carrying Amount of Intangible Assets) (Details)
36: R81 Borrowings and Other Secured Financings HTML 44K
(Narratives) (Details)
123: R82 Borrowings and Other Secured Financings HTML 52K
(Components of Long-term Borrowings) (Details)
64: R83 Borrowings and Other Secured Financings (Other HTML 43K
Secured Financings) (Details)
98: R84 Derivative Instruments and Hedging Activities HTML 83K
(Other Disclosures) (Details)
105: R85 Derivative Instruments and Hedging Activities HTML 98K
(Components of Derivative Products) (Details)
35: R86 Derivative Instruments and Hedging Activities HTML 72K
(Fair Value of OTC Derivatives in a Gain Position)
(Details)
37: R87 Derivative Instruments and Hedging Activities HTML 121K
(Fair Value of Derivative Instruments Designated
and Not Designated as Accounting Hedges by Type of
Derivative Contract on a Gross Basis) (Details)
120: R88 Derivative Instruments and Hedging Activities HTML 70K
(Gains or Losses on Derivative Instruments,
Related Hedge Items and Hedge Ineffectiveness)
(Details)
31: R89 Derivative Instruments and Hedging Activities HTML 161K
(Notional and Fair Value of Protection Sold and
Purchased through Credit Default Swaps) (Details)
92: R90 Commitments, Guarantees and Contingencies HTML 73K
(Narrative) (Details)
88: R91 Commitments, Guarantees and Contingencies HTML 88K
(Commitments) (Details)
109: R92 Commitments, Guarantees and Contingencies HTML 86K
(Obligations under Guarantee Arrangements)
(Details)
87: R93 Regulatory Requirements (Narrative) (Details) HTML 62K
72: R94 Regulatory Requirements (Capital Measures) HTML 69K
(Details)
114: R95 Regulatory Requirements (Significant U.S. Bank HTML 63K
Operating Subsidiaries' Capital) (Details)
70: R96 Redeemable Noncontrolling Interests and Total HTML 42K
Equity (Narrative) (Details)
44: R97 Redeemable Noncontrolling Interests and Total HTML 50K
Equity (Redeemable Noncontrolling Interests)
(Details)
79: R98 Redeemable Noncontrolling Interests and Total HTML 59K
Equity (Components of Accumulated Other
Comprehensive Income (Loss)) (Details)
74: R99 Earnings Per Common Share (Calculation of Basic HTML 133K
and Diluted EPS) (Details)
57: R100 Earnings Per Common Share (Antidilutive Securities HTML 44K
Excluded from the Computation of Diluted EPS)
(Details)
131: R101 Interest Income and Interest Expense (Details) HTML 84K
107: R102 Employee Benefit Plans (Components of Net Periodic HTML 62K
Benefit Expense) (Details)
86: R103 Income Taxes (Reconciliation of the Provision for HTML 43K
(Benefit from) Income Taxes and the U.S. Federal
Statutory Income Tax Rate) (Details)
26: R104 Segment and Geographic Information (Selected HTML 141K
Financial Information by Segments) (Details)
116: R105 Segment and Geographic Information (Assets by HTML 47K
Segments) (Details)
124: R106 Segment and Geographic Information (Net Revenues HTML 46K
and Assets by Geographic Area) (Details)
118: R107 Equity Method Investments (Narratives) (Details) HTML 59K
82: R108 Discontinued Operations (Details) HTML 52K
33: R109 Subsequent Events (Details) HTML 43K
127: XML IDEA XML File -- Filing Summary XML 206K
52: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 6.42M
14: EX-101.INS XBRL Instance -- ms-20130331 XML 13.49M
16: EX-101.CAL XBRL Calculations -- ms-20130331_cal XML 481K
17: EX-101.DEF XBRL Definitions -- ms-20130331_def XML 3.24M
18: EX-101.LAB XBRL Labels -- ms-20130331_lab XML 6.00M
19: EX-101.PRE XBRL Presentations -- ms-20130331_pre XML 4.18M
15: EX-101.SCH XBRL Schema -- ms-20130331 XSD 691K
53: ZIP XBRL Zipped Folder -- 0001193125-13-204446-xbrl Zip 743K
| EX-31.2 |
EXHIBIT 31.2
Certification
I, Ruth Porat, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Morgan Stanley; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: May 7, 2013
| /s/ RUTH PORAT |
| Ruth Porat |
| Executive Vice President and Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/7/13 | 424B2, FWP, SC 13G, SC 13G/A, UPLOAD | ||
| For Period end: | 3/31/13 | 13F-HR | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/21 Morgan Stanley 10-K 12/31/20 225:50M |